1 - 25 of 62 results for author:"Claesson-Welsh L." in Literature citations
Results Customize
› Repeat search in UniProtKB (41)
| VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. Sun Z., Li X., Massena S., Kutschera S., Padhan N., Gualandi L., Sundvold-Gjerstad V., Gustafsson K., Choy W.W., Zang G. et al. J. Exp. Med. 209:1363-1377(2012) · Mapped (6) |
| Genetic deficiency in plasma protein HRG enhances tumor growth and metastasis by exacerbating immune escape and vessel abnormalization. Tugues S., Honjo S., Konig C., Noguer O., Hedlund M., Botling J., Deschoemaeker S., Wenes M., Rolny C., Jahnen-Dechent W. et al. Cancer Res. 72:1953-1963(2012) · UniProtKB (1) |
| Blood vessels as targets in tumor therapy. Claesson-Welsh L. Ups. J. Med. Sci. 117:178-186(2012) · Mapped (1) |
| Signal transduction by vascular endothelial growth factor receptors. Koch S., Tugues S., Li X., Gualandi L., Claesson-Welsh L. Biochem. J. 437:169-183(2011) · UniProtKB (3) |
| HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Rolny C., Mazzone M., Tugues S., Laoui D., Johansson I., Coulon C., Squadrito M.L., Segura I., Li X., Knevels E. et al. |
| A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression. Geretti E., van Meeteren L.A., Shimizu A., Dudley A.C., Claesson-Welsh L., Klagsbrun M. Mol. Cancer Res. 8:1063-1073(2010) · Mapped (7) |
| p21-activated kinase 4 phosphorylation of integrin beta5 Ser-759 and Ser-762 regulates cell migration. Li Z., Zhang H., Lundin L., Thullberg M., Liu Y., Wang Y., Claesson-Welsh L., Stromblad S. J. Biol. Chem. 285:23699-23710(2010) · UniProtKB (1) |
| Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Van de Veire S., Stalmans I., Heindryckx F., Oura H., Tijeras-Raballand A., Schmidt T., Loges S., Albrecht I., Jonckx B., Vinckier S. et al. Cell 141:178-190(2010) · Mapped (7) |
| T cell specific adapter protein (TSAd) interacts with Tec kinase ITK to promote CXCL12 induced migration of human and murine T cells. Berge T., Sundvold-Gjerstad V., Granum S., Andersen T.C., Holthe G.B., Claesson-Welsh L., Andreotti A.H., Inngjerdingen M., Spurkland A. PLoS ONE 5:e9761-e9761(2010) · Mapped (26) |
| Vascular endothelial growth factor B controls endothelial fatty acid uptake. Hagberg C.E., Falkevall A., Wang X., Larsson E., Huusko J., Nilsson I., van Meeteren L.A., Samen E., Lu L., Vanwildemeersch M. et al. Nature 464:917-921(2010) · Mapped (9) |
| VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. Nilsson I., Bahram F., Li X., Gualandi L., Koch S., Jarvius M., Soderberg O., Anisimov A., Kholova I., Pytowski B. et al. |
| Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. Bhattacharya R., Kwon J., Li X., Wang E., Patra S., Bida J.P., Bajzer Z., Claesson-Welsh L., Mukhopadhyay D. J. Cell. Sci. 122:1025-1034(2009) · Mapped (1) |
| Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. Mellberg S., Dimberg A., Bahram F., Hayashi M., Rennel E., Ameur A., Westholm J.O., Larsson E., Lindahl P., Cross M.J. et al. |
| Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Kawamura H., Li X., Goishi K., van Meeteren L.A., Jakobsson L., Cebe-Suarez S., Shimizu A., Edholm D., Ballmer-Hofer K., Kjellen L. et al. Blood 112:3638-3649(2008) · Mapped (1) |
| Laminin deposition is dispensable for vasculogenesis but regulates blood vessel diameter independent of flow. Jakobsson L., Domogatskaya A., Tryggvason K., Edgar D., Claesson-Welsh L. FASEB J. 22:1530-1539(2008) · Mapped (3) |
| alphaB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Dimberg A., Rylova S., Dieterich L.C., Olsson A.K., Schiller P., Wikner C., Bohman S., Botling J., Lukinius A., Wawrousek E.F. et al. Blood 111:2015-2023(2008) · Mapped (7) |
| FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin. Magnusson P.U., Dimberg A., Mellberg S., Lukinius A., Claesson-Welsh L. Blood 110:4214-4222(2007) · Mapped (13) |
| Angiomotin regulates endothelial cell migration during embryonic angiogenesis. Aase K., Ernkvist M., Ebarasi L., Jakobsson L., Majumdar A., Yi C., Birot O., Ming Y., Kvanta A., Edholm D. et al. Genes Dev. 21:2055-2068(2007) · Mapped (22) |
| Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro. Magnusson P.U., Looman C., Ahgren A., Wu Y., Claesson-Welsh L., Heuchel R.L. Arterioscler. Thromb. Vasc. Biol. 27:2142-2149(2007) · Mapped (7) |
| Platelet-derived growth factor receptor-beta promotes early endothelial cell differentiation. Rolny C., Nilsson I., Magnusson P., Armulik A., Jakobsson L., Wentzel P., Lindblom P., Norlin J., Betsholtz C., Heuchel R. et al. Blood 108:1877-1886(2006) · Mapped (13) |
| VEGF receptor signalling - in control of vascular function. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. Nat. Rev. Mol. Cell Biol. 7:359-371(2006) · Mapped (20) |
| Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein. Dixelius J., Olsson A.K., Thulin A., Lee C., Johansson I., Claesson-Welsh L. Cancer Res. 66:2089-2097(2006) · UniProtKB (2) |
| The anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent manner. Vanwildemeersch M., Olsson A.K., Gottfridsson E., Claesson-Welsh L., Lindahl U., Spillmann D. J. Biol. Chem. 281:10298-10304(2006) · UniProtKB (1) · Mapped (2) |
| Proteomic analysis of vascular endothelial growth factor-induced endothelial cell differentiation reveals a role for chloride intracellular channel 4 (CLIC4) in tubular morphogenesis. Bohman S., Matsumoto T., Suh K., Dimberg A., Jakobsson L., Yuspa S., Claesson-Welsh L. J. Biol. Chem. 280:42397-42404(2005) · UniProtKB (1) · Mapped (10) |
| VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. Matsumoto T., Bohman S., Dixelius J., Berge T., Dimberg A., Magnusson P., Wang L., Wikner C., Qi J.H., Wernstedt C. et al. |